Atropine Sulfate 2.0 mg auto-injector
Solicitation number W6369-20-A019/A
Publication date
Closing date and time 2020/01/13 13:00 EST
Last amendment date
Description
Description:
Trade Agreement: Canadian Free Trade agreement (CFTA)
Tendering Procedures: All interested suppliers may submit a bid
Competitive Procurement Strategy: Lowest/Lower Bid
Comprehensive Land Claim Agreement: No
Nature of Requirement:
The Department of National Defence has a requirement for Atropine Sulfate Auto-Injectors 2.0 mg to be delivered to Canadian Forces Base Petawawa, Central Medical Equipment Depot,
Petawawa, Ontario.
Firm Quantity:
The requirement is for 500 units of Atropine Sulfate Auto-Injectors 2.0 mg. Upon request the contractor must provide an additional quantity up to 1,000 units until 31 March 2023.
Delivery Period:
The firm quantity must be completed by no later than 15 February, 2020.
Shelf Life:
Must have a minimum shelf life of 2 years.
Delivery Date: Above-mentioned
The Crown retains the right to negotiate with suppliers on any procurement.
Documents may be submitted in either official language of Canada.
Contract duration
Refer to the description above for full details.
Trade agreements
-
Canadian Free Trade Agreement (CFTA)
Partner with another business
The functionality to add your company name to the list of interested businesses is temporarily unavailable.
This list does not replace or affect the tendering procedures for this procurement process. Businesses are still required to respond to bid solicitations, and to compete based on the set criteria. For more information please read the Terms of use.
Contact information
Contracting organization
- Organization
-
Department of National Defence
- Address
-
101 Colonel By DrOttawa, Ontario, K1A0K2Canada
- Contracting authority
- Sarwar. Ali
- Email
- Ali.Sarwar@forces.gc.ca
Buying organization(s)
- Organization
-
Department of National Defence
- Address
-
101 Colonel By DrOttawa, Ontario, K1A0K2Canada
Bidding details
Full details regarding this tender opportunity are available in the documents below. Click on the document name to download the file. Contact the contracting officer if you have any questions regarding these documents.
| Document title | Amendment no. | Language | Unique downloads | Date added |
|---|---|---|---|---|
| w6369-20-a019_amendment_3-en.pdf | 003 |
English
|
12 | |
| w6369-20-a019_amendment_3-_fr.pdf | 003 |
French
|
1 | |
| w6369-20-a019_amendment_2-en.pdf | 002 |
English
|
9 | |
| w6369-20-a019_amendment_2-_fr.pdf | 002 |
French
|
2 | |
| w6369-20-a019_-_amendment_1_-_en.pdf | 001 |
English
|
10 | |
| w6369-20-a019_-_amendment_1_-_fr.pdf | 001 |
French
|
2 | |
| w6369-20-a019_rfp.pdf | 000 |
English
|
35 | |
| w6369-20-a019_ddp-fr.pdf | 000 |
French
|
13 |
Access the Getting started page for details on how to bid, and more.
Related notices
Contracts awarded (1) This tender notice has 1 related award notices. Click to collapse
This is a list of other contracts that were awarded related to solicitation number W6369-20-A019/A. Click the link under “More details” to view the contract details.
Company name
|
Contract number
|
Amendment date
|
Award date
|
More details |
|---|---|---|---|---|
| Rafa Laboratories Limited | W6369-20-A019 | Not available | 2020/02/07 | Viewthe details of contract W6369-20-A019 for Rafa Laboratories Limited |
Eligibility and terms and conditions
Government of Canada tender and awards notices, solicitation documents, and other attachments are fully accessible and available free of charge and without having to register on CanadaBuys.
Information may be available on another source prior to being available on CanadaBuys. You may have received this information through a third-party distributor. The Government of Canada is not responsible for any tender notices and/or related documents and attachments not accessed directly from CanadaBuys.canada.ca.
Government of Canada tender or award notices carry an OpenGovernment License - Canada that governs its use. Related solicitation documents and/or tender attachments are copyright protected. Please refer to our terms and conditions page for more information.
